Miszkiel Aleksandra, Wojciechowski Marek
Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, ul. Narutowicza 11/12, 80-233 Gdańsk, Poland.
Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, ul. Narutowicza 11/12, 80-233 Gdańsk, Poland.
J Mol Graph Model. 2017 Nov;78:14-25. doi: 10.1016/j.jmgm.2017.09.009. Epub 2017 Sep 18.
Glucosamine-6-phosphate synthase (EC 2.6.1.16) is responsible for catalysis of the first and practically irreversible step in hexosamine metabolism. The final product of this pathway, uridine 5' diphospho N-acetyl-d-glucosamine (UDP-GlcNAc), is an essential substrate for assembly of bacterial and fungal cell walls. Moreover, the enzyme is involved in phenomenon of hexosamine induced insulin resistance in type II diabetes, which makes of it a potential target for anti-fungal, anti-bacterial and anti-diabetic therapy. The crystal structure of isomerase domain from human pathogenic fungus Candida albicans has been solved recently but it doesn't reveal the molecular mechanism details of inhibition taking place under UDP-GlcNAc influence, the unique feature of eukaryotic enzyme. The following study is a continuation of the previous research based on comparative molecular dynamics simulations of the structures with and without the enzyme's physiological inhibitor (UDP-GlcNAc) bound. The models used for this study included fructose-6-phosphate, one of the enzyme's substrates in its binding pocket. The simulation results studies demonstrated differences in mobility of the compared structures. Some amino acid residues were determined, for which flexibility is evidently different between the models. Importantly, it has been confirmed that the most fixed residues are related to the inhibitor binding process and to the catalysis reaction. The obtained results constitute an important step towards understanding of the inhibition that GlcN-6-P synthase is subjected by UDP-GlcNAc molecule.
葡糖胺-6-磷酸合酶(EC 2.6.1.16)负责催化己糖胺代谢的第一步且几乎不可逆的步骤。该途径的最终产物尿苷5'-二磷酸-N-乙酰-D-葡糖胺(UDP-GlcNAc)是细菌和真菌细胞壁组装的必需底物。此外,该酶还参与II型糖尿病中己糖胺诱导的胰岛素抵抗现象,这使其成为抗真菌、抗细菌和抗糖尿病治疗的潜在靶点。最近已解析了人类致病真菌白色念珠菌异构酶结构域的晶体结构,但它并未揭示在UDP-GlcNAc影响下发生抑制作用的分子机制细节,而这是真核酶的独特特征。以下研究是基于对结合和未结合该酶生理抑制剂(UDP-GlcNAc)的结构进行比较分子动力学模拟的先前研究的延续。本研究使用的模型包括果糖-6-磷酸,它是该酶结合口袋中的一种底物。模拟结果研究表明了所比较结构在流动性方面的差异。确定了一些氨基酸残基,其在各模型之间的灵活性明显不同。重要的是,已证实最固定的残基与抑制剂结合过程和催化反应有关。所获得的结果是朝着理解葡糖胺-6-磷酸合酶受UDP-GlcNAc分子抑制作用迈出的重要一步。